Malignant neoplasm of cortex of left adrenal gland
ICD-10 C74.02 is a billable code used to indicate a diagnosis of malignant neoplasm of cortex of left adrenal gland.
C74.02 refers to a malignant neoplasm located in the cortex of the left adrenal gland. The adrenal glands, situated atop each kidney, are responsible for producing hormones that regulate metabolism, immune response, blood pressure, and stress responses. Malignant neoplasms of the adrenal cortex can lead to significant hormonal imbalances, resulting in conditions such as Cushing's syndrome, Conn's syndrome, or adrenal insufficiency. Symptoms may include hypertension, weight gain, fatigue, and abnormal glucose metabolism. Diagnosis typically involves imaging studies such as CT or MRI scans, along with biochemical tests to assess hormone levels. Treatment often requires surgical intervention, such as adrenalectomy, and may be followed by chemotherapy or radiation therapy depending on the tumor's characteristics. Accurate coding is essential for proper treatment planning and reimbursement, as well as for tracking outcomes in patients with adrenal malignancies.
Detailed hormone level assessments, imaging results, and clinical symptoms.
Patients presenting with symptoms of hormonal excess or deficiency, requiring evaluation of adrenal function.
Endocrinologists must ensure comprehensive documentation of hormonal assays and imaging studies to support the diagnosis.
Pathology reports, imaging studies, and treatment plans.
Patients diagnosed with adrenal tumors undergoing surgical or medical management.
Oncologists need to document tumor staging and grading accurately to support coding and treatment decisions.
Used when a patient undergoes surgical removal of the left adrenal gland due to malignancy.
Operative reports detailing the procedure and findings.
Surgeons must document the extent of the surgery and any complications.
Accurate coding of C74.02 is crucial for proper treatment planning, reimbursement, and tracking patient outcomes. It ensures that healthcare providers receive appropriate compensation for the care provided and helps in the management of adrenal malignancies.
